Biophysical and pharmacological properties of glucagon-like peptide-1 in rats under isoflurane anesthesia

Anesthesia and Analgesia

Volumn 115, Issue 1, 2012, Pages 62-69

  Kawano, Takashi ^a   Tanaka, Katsuya ^a   Chi, Haidong ^a   Eguchi, Satoru ^b   Yamazaki, Fumimoto ^a   Kitamura, Sonoe ^a   Kumagai, Naoko ^c   Yokoyama, Masataka ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ESCIN; DIPEPTIDYL PEPTIDASE IV; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; ISOFLURANE; OXYGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE DEPOLARIZATION; CELL MEMBRANE POTENTIAL; CONTROLLED STUDY; DIET RESTRICTION; ENTEROENDOCRINE CELL; ENZYME ACTIVITY; GLUCOSE TOLERANCE TEST; GLYCEMIC CONTROL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INHALATION ANESTHESIA; INSULIN LIKE ACTIVITY; INSULIN RELEASE; MALE; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PATCH CLAMP; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; WHOLE CELL;

ANESTHETICS, INHALATION; ANIMALS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CELL LINE; DIPEPTIDYL PEPTIDASE 4; ENTEROENDOCRINE CELLS; GLUCAGON-LIKE PEPTIDE 1; HOMEOSTASIS; HUMANS; INSULIN; ISLETS OF LANGERHANS; ISOFLURANE; MALE; MEMBRANE POTENTIALS; PATCH-CLAMP TECHNIQUES; PERFUSION; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; STOMACH; TIME FACTORS;

EID: 84862989421     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e318253cbf0     Document Type: Article

References (31)

1. Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev 2007;87:1409-39
2. Ahrén B, Schmitz O. GLP-1 receptor agonists and DPP-4 inhibitors in the treatment of type 2 diabetes. Horm Metab Res 2004;36:867-76
3. Bose AK, Mocanu MM, Carr RD, Yellon DM. Myocardial ischaemia-reperfusion injury is attenuated by intact glucagon like peptide-1 (GLP-1) in the in vitro rat heart and may involve the p70s6K pathway. Cardiovasc Drugs Ther 2007;21:253-6
4. Zhao T, Parikh P, Bhashyam S, Bolukoglu H, Poornima I, Shen YT, Shannon RP. Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts. J Pharmacol Exp Ther 2006;317:1106-13
5. Nikolaidis LA, Elahi D, Hentosz T, Doverspike A, Huerbin R, Zourelias L, Stolarski C, Shen YT, Shannon RP. Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy. Circulation 2004;110:955-61
6. Saho S, Kadota Y, Sameshima T, Miyao J, Tsurumaru T, Yoshimura N. The effects of sevoflurane anesthesia on insulin secretion and glucose metabolism in pigs. Anesth Analg 1997;84:1359-65
7. Tanaka T, Nabatame H, Tanifuji Y. Insulin secretion and glucose utilization are impaired under general anesthesia with sevoflurane as well as isoflurane in a concentration-independent manner. J Anesth 2005;19:277-81
8. Tanaka K, Kawano T, Tomino T, Kawano H, Okada T, Oshita S, Takahashi A, Nakaya Y. Mechanisms of impaired glucose tolerance and insulin secretion during isoflurane anesthesia. Anesthesiology 2009;111:1044-51
9. Tanaka K, Kawano T, Tsutsumi YM, Kinoshita M, Kakuta N, Hirose K, Kimura M, Oshita S. Differential effects of propofol and isoflurane on glucose utilization and insulin secretion. Life Sci 2011;88:96-103
10. Kirino Y, Sato Y, Kamimoto T, Kawazoe K, Minakuchi K, Nakahori Y. Interrelationship of dipeptidyl peptidase IV (DPP4) with the development of diabetes, dyslipidaemia and nephropathy: A streptozotocin-induced model using wild-type and DPP4-deficient rats. J Endocrinol 2009;200:53-61
11. Ikeuchi M, Fujimoto WY, Cook DL. Rat islet cells have glucosedependent periodic electrical activity. Horm Metab Res 1984;16:125-7
12. Prieto PG, Cancelas J, Villanueva-Penacarrillo ML, Valverde I, Malaisse WJ. Effects of an olive oil-enriched diet on plasma GLP-1 concentration and intestinal content, plasma insulin concentration, and glucose tolerance in normal rats. Endocrine 2005;26:107-15
13. Balkan B, Kwasnik L, Miserendino R, Holst JJ, Li X. Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7-36 amide) concentrations and improves oral glucose tolerance in obese Zucker rats. Diabetologia 1999;42:1324-31
14. Reimer RA, Darimont C, Gremlich S, Nicolas-Métral V, Rüegg UT, Macé K. A human cellular model for studying the regulation of glucagon-like peptide-1 secretion. Endocrinology 2001;142:4522-8
15. Lauffer LM, Iakoubov R, Brubaker PL. GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell. Diabetes 2009;58:1058-66
16. Tanaka K, Kawano T, Nakamura A, Nazari H, Kawahito S, Oshita S, Takahashi A, Nakaya Y. Isoflurane activates sarcolemmal adenosine triphosphate-sensitive potassium channels in vascular smooth muscle cells: A role for protein kinase A. Anesthesiology 2007;106:984-91
17. Taheri S, Halsey MJ, Liu J, Eger EI II, Koblin DD, Laster MJ. What solvent best represents the site of action of inhaled anesthetics in humans, rats, and dogs? Anesth Analg 1991;72:627-34
18. Persson K, Gingerich RL, Nayak S, Wada K, Wada E, Ahrén B. Reduced GLP-1 and insulin responses and glucose intolerance after gastric glucose in GRP receptor-deleted mice. Am J Physiol Endocrinol Metab 2000;279:E956-62
19. Meneilly GS, Demuth HU, McIntosh CH, Pederson RA. Effect of ageing and diabetes on glucose-dependent insulinotropic polypeptide and dipeptidyl peptidase IV responses to oral glucose. Diabet Med 2000;17:346-50
20. Ryskjaer J, Deacon CF, Carr RD, Krarup T, Madsbad S, Holst J, Vilsboøll T. Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake. Eur J Endocrinol 2006;155:485-93
21. Kitahara Y, Miura K, Yasuda R, Kawanabe H, Ogawa S, Eto Y. Nateglinide stimulates glucagon-like peptide-1 release by human intestinal L cells via a K(ATP) channel-independent mechanism. Biol Pharm Bull 2011;34:671-6
22. Scrocchi LA, Marshall BA, Cook SM, Brubaker PL, Drucker DJ. Glucose homeostasis in mice with disruption of GLP-1 receptor signaling. Diabetes 1998;47:632-9
23. Schirra J, Sturm K, Leicht P, Arnold R, Göke B, Katschinski M. Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans. J Clin Invest 1998;101:1421-30
24. Koster JC, Permutt MA, Nichols CG. Diabetes and insulin secretion: The ATP-sensitive K-channel (KATP) connection. Diabetes 2005;54:3065-72
25. Holz GG IV, Kü htreiber WM, Habener JF. Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37). Nature 1993;361:362-5
26. Ding WG, Kitasato H, Matsuura H. Involvement of calmodulin in glucagon-like peptide 1(7-36) amide-induced inhibition of the ATP-sensitive K-channel in mouse pancreatic-cells. Exp Physiol 2001;86:331-9
27. Gu W, Pagel PS, Warltier DC, Kersten JR. Modifying cardiovascular risk in diabetes mellitus. Anesthesiology 2003;98:774-9
28. Maerz LL, Akhtar S. Perioperative glycemic management in 2011:paradigm shifts. Curr Opin Crit Care 2011;17:370-5
29. Thorens B. Expression cloning of the pancreatic -cell receptor for the gluco-incretin hormone glucagon-like peptide 1. Proc Natl Acad Sci U S A 1992;89:8641-5
30. Bloomgarden ZT. Gut-derived incretin hormones and new therapeutic approaches. Diabetes Care 2004;27:2554-9
31. Mojsov S, Weir GC, Habener JF. Insulinotropin:glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J Clin Invest 1987;79:616-9